Heart Disease Clinical Trial
Official title:
Healing Touch Intervention in Post-Cardiac Event Patients Prior to Starting a Cardiac Rehab Program
The purpose of the investigators proposed randomized, controlled study is to examine the
effect of 6 one hour treatments of Healing Touch (HT) over 3 weeks on post-cardiac event
patients, while they wait to enter a Cardiac Rehab (CR) program.Patients enrolled in the
Scripps Center for Integrative Medicine (SCIM) Cardiac Rehab Program typically experience a
waiting period of 3 weeks, or sometimes more, before starting the program.
Secondary aims of the proposed study are to evaluate the effect of HT on CR program outcome
measures of METs, BMI, physical and mental well-being, and attendance in this population.
New participants in the CR program who qualify and agree to participate in the study will be
consented and randomly assigned to the Intervention Group who will receive Healing Touch
therapy, or to the Control Group, which will not receive HT.
At baseline both groups will complete the Dartmouth Quality of Life and SF-36 Health Surveys.
The questionnaires will be repeated at the end of the 3 week study period and at the end of
the 3 months SCIM CR program.
An effect size of 15% was chosen, with an alpha level of 0.05, 80% power, 95% confidence
level, and using a two-tailed test, it was determined that a sample size of 56 patients in
each group would be needed for between group comparisons. To account for potential attrition
the study will enroll 124 subjects, 62 in each group.
Our rationale is that Healing Touch, in addition to standard medical care will reduce
post-cardiac event stress and anxiety symptoms in patients waiting to enter a cardiac rehab
program, as measured by the Dartmouth Quality of Life Index and the SF36 questionnaire.
Further, the investigators suggest that Healing Touch treatments will improve patient's final
outcomes of the 12 week CR program.
Status | Recruiting |
Enrollment | 124 |
Est. completion date | June 2019 |
Est. primary completion date | December 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 95 Years |
Eligibility |
Inclusion Criteria: 1. Must have referral to Cardiac Rehab at the Scripps Center for Integrative Medicine. 2. Must have had a cardiac event which precede the CR referral. 3. Must be willing to come to the Scripps Center for Integrative Medicine twice a week for 3 weeks. 4. Must be able to understand English Exclusion Criteria: 1. Patients under 18 years. 2. Unable to understand English |
Country | Name | City | State |
---|---|---|---|
United States | Scripps Center for Integrative Medicine | La Jolla | California |
Lead Sponsor | Collaborator |
---|---|
Scripps Health |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants with an improvement in stress and anxiety symptoms as measured by Dartmouth Quality of Life Index scores | Dartmouth Quality of Life Index questionnaires will be obtained at enrollment and after 3 weeks of HT (or no intervention for the control group). | 3 weeks | |
Primary | Number of participants with an improvement in stress and anxiety symptoms as measured by SF-36 scores | SF-36 questionnaires will be obtained at enrollment and after 3 weeks of HT (or no intervention for the control group). | 3 weeks | |
Secondary | Number of participants with an improvement of Metabolic Equivalent of Task (MET) | MET: Metabolic Equivalent of Task is measured at the start of Cardiac Rehab and at 3 months completion. | 3 months | |
Secondary | Number of participants with an improvement in BMI: Body Mass Index | BMI: Body Mass Index, which is measured at the start of Cardiac Rehab and at 3 months completion. | 3 months | |
Secondary | Number of participants with an improvement in stress and anxiety symptoms as measured by Dartmouth Quality of Life Index scores | Dartmouth Quality of Life Index scores will be obtained at the start of cardiac rehab and at completion. | 3 months | |
Secondary | Number of cardiac rehab sessions each participant attended will be recorded | To determine cardiac rehab attendance, study participants' number of sessions will be recorded. The program ends after 36 sessions (3 month). Not all participants complete all 36 sessions. | 3 months | |
Secondary | Number of participants with an improvement in stress and anxiety symptoms as measured by SF-36 scores | SF-36 scores will be obtained at the start of cardiac rehab and at completion. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03481322 -
Low Sodium Cooking Study
|
N/A | |
Completed |
NCT00001638 -
Magnetic Resonance Imaging of the Blood Vessels of the Heart
|
||
Completed |
NCT02376244 -
The Health Impact of High Intensity Exercise Training With Intervals During Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02523144 -
Dexmedetomidine in Children Having Transthoracic Echocardiography
|
Phase 4 | |
Completed |
NCT02277379 -
Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery
|
N/A | |
Completed |
NCT01871090 -
Remote Device Interrogation In The Emergency Department
|
N/A | |
Completed |
NCT02045641 -
Pleural and Pericardial Effusion Following Open Heart Surgery
|
N/A | |
Active, not recruiting |
NCT01400490 -
Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid Study
|
N/A | |
Completed |
NCT01192360 -
Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung Disease
|
Phase 3 | |
Terminated |
NCT00935766 -
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
|
Phase 3 | |
Completed |
NCT00745446 -
The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation
|
N/A | |
Completed |
NCT00140816 -
Dairy Products and Metabolic Effects (Norwegian Part)
|
N/A | |
Completed |
NCT00178620 -
Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization
|
Phase 4 | |
Completed |
NCT00013949 -
Cardiovascular Vulnerability to Particulate Exposure
|
N/A | |
Completed |
NCT01952171 -
The Genetic Basis of Congenital Heart Disease in Africa
|
||
Recruiting |
NCT02933892 -
Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization
|
Phase 4 | |
Completed |
NCT02923518 -
Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes)
|
||
Withdrawn |
NCT02838355 -
Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients
|
N/A | |
Terminated |
NCT02282163 -
Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography
|
Phase 3 | |
Active, not recruiting |
NCT02260466 -
Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.
|
N/A |